EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent
N Mottet, RCN van den Bergh, E Briers… - European urology, 2021 - Elsevier
Objective To present a summary of the 2020 version of the European Association of Urology
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …
Stereotactic body radiation therapy for localized prostate cancer: a systematic review and meta-analysis of over 6,000 patients treated on prospective studies
Purpose Utilization of stereotactic body radiation therapy (SBRT) for treatment of localized
prostate cancer is increasing. Guidelines and payers variably support the use of prostate …
prostate cancer is increasing. Guidelines and payers variably support the use of prostate …
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3 …
AC Tree, P Ostler, H van der Voet, W Chu… - The Lancet …, 2022 - thelancet.com
Background Localised prostate cancer is commonly treated with external beam radiotherapy
and moderate hypofractionation is non-inferior to longer schedules. Stereotactic body …
and moderate hypofractionation is non-inferior to longer schedules. Stereotactic body …
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 …
A Widmark, A Gunnlaugsson, L Beckman… - The Lancet, 2019 - thelancet.com
Background Hypofractionated radiotherapy for prostate cancer has gained increased
attention due to its proposed high radiation-fraction sensitivity. Recent reports from studies …
attention due to its proposed high radiation-fraction sensitivity. Recent reports from studies …
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international …
DH Brand, AC Tree, P Ostler, H van der Voet… - The Lancet …, 2019 - thelancet.com
Background Localised prostate cancer is commonly treated with external-beam
radiotherapy. Moderate hypofractionation has been shown to be non-inferior to conventional …
radiotherapy. Moderate hypofractionation has been shown to be non-inferior to conventional …
Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis
Background Randomised trials have investigated various androgen deprivation therapy
(ADT) intensification strategies in men receiving radiotherapy for the treatment of prostate …
(ADT) intensification strategies in men receiving radiotherapy for the treatment of prostate …
[HTML][HTML] COVID-19: Global radiation oncology's targeted response for pandemic preparedness
As the global COVID-19 pandemic escalates there is a need within radiation oncology to
work to support our patients in the best way possible. Measures are required to reduce …
work to support our patients in the best way possible. Measures are required to reduce …
Long-term outcomes of stereotactic body radiotherapy for low-risk and intermediate-risk prostate cancer
AU Kishan, A Dang, AJ Katz, CA Mantz… - JAMA network …, 2019 - jamanetwork.com
Importance Stereotactic body radiotherapy harnesses improvements in technology to allow
the completion of a course of external beam radiotherapy treatment for prostate cancer in the …
the completion of a course of external beam radiotherapy treatment for prostate cancer in the …
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised …
P Fransson, P Nilsson, A Gunnlaugsson… - The Lancet …, 2021 - thelancet.com
Summary Background The HYPO-RT-PC trial compared conventionally fractionated
radiotherapy with ultra-hypofractionated radiotherapy in patients with localised prostate …
radiotherapy with ultra-hypofractionated radiotherapy in patients with localised prostate …
Hyaluronic acid spacer for hypofractionated prostate radiation therapy: A randomized clinical trial
NF Mariados, PF Orio, Z Schiffman, TJ Van… - JAMA …, 2023 - jamanetwork.com
Importance Hypofractionated radiation therapy (RT) for prostate cancer has been associated
with greater acute grade 2 gastrointestinal (GI) toxic effects compared with conventionally …
with greater acute grade 2 gastrointestinal (GI) toxic effects compared with conventionally …